Sorrento Investor Suit Survives Dismissal Bid
A Delaware judge refused Wednesday to dismiss a suit against directors of biopharma firm Sorrento Therapeutics Inc. over allegedly self-serving stock grants following an asset transfer, saying it's on the defendants...To view the full article, register now.
Already a subscriber? Click here to view full article